Jeffrey Tosoian

October 31, 2024

Jeffrey Tosoian named chair of EDRN Prostate/GU Cancer Collaborative

The EDRN works to discover, develop and validate biomarkers and imaging methods to detect early-stage cancers, assess risk for developing cancer, and translate these tools into clinical tests.

By Craig Boerner
(iStock image)
April 18, 2024

New urine test has higher diagnostic accuracy for prostate cancer

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the U.S.

By Tom Wilemon